Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Hoba Therapeutics has raised $24.8M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Hoba Therapeutics's investors include Novo Holdings, European Innovation Council, Indaco Venture Partners, EIR Ventures, Export and Investment Fund.
Hoba Therapeutics is headquartered in Copenhagen, Denmark.
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Hoba Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hoba Therapeutics — Funding & Investors." VCBacked, December 11, 2023, https://www.vcbacked.co/company/hoba-therapeutics. Accessed July 20, 2026.
VCBacked. (2023). Hoba Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/hoba-therapeutics
{{cite web |title=Hoba Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hoba-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated